# Abvc Biopharma, Inc.: Form DEF 14A, filed Sep 29, 2026

- Company: [Abvc Biopharma, Inc.](/companies/abvc.md) (CIK 1173313)
- Form: DEF 14A
- Filed: 2026-09-29
- Accepted by EDGAR: Sep 29, 2026, 12:22 ET
- Period: 2026-10-28
- Accession: 0001213900-26-104509
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1173313/000121390026104509/ea0306577-def14a_abvc.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173313/000121390026104509/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1173313/000121390026104509/ea0306577-def14a_abvc.htm

Filed Sep 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-104509. Last ingested by Listed: Nov 14, 2026, 21:07 ET. No prices; not investment advice.
